Trial Profile
Pharmacokinetics and safety of GS-5806 in Japanese and Caucasian healthy volunteers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Presatovir (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions; Pharmacokinetics
- 17 Apr 2018 Results of pooled data from two phase 1 trial, were published in the Journal of Clinical Pharmacology.
- 17 Dec 2015 New trial record